Your browser doesn't support javascript.
loading
Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
Cao, Hong; Qiang, Li; Chen, Jing; Johnson, Katherine M; McNiven, Mark A; Razidlo, Gina L.
Afiliação
  • Cao H; Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Qiang L; Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Chen J; Department of Biochemistry & Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Johnson KM; Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • McNiven MA; Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Razidlo GL; Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
PLoS One ; 16(3): e0248111, 2021.
Article em En | MEDLINE | ID: mdl-33740019
The process by which tumor cells mechanically invade through the surrounding stroma into peripheral tissues is an essential component of metastatic dissemination. Matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation plays an important role in this invasive process. Defining the contribution and interaction between these MMPs during invasion remains a key interest in the development of targeted anti-metastatic therapies. In this study we have utilized multiple different stromal fibroblasts and tumor cells to define the relative contributions between cancer cells and stromal cells during MMP-dependent matrix remodeling and pancreatic (PDAC) tumor cell invasion. We find that tumor cells co-cultured with the conditioned medium from stromal fibroblasts exhibited a substantial increase in invadopodial-based matrix degradation and transwell invasion. This increase is dependent on pro-MMP2 expressed and secreted by stromal fibroblasts. Further, the pro-MMP2 from the stromal fibroblasts is activated by MT1-MMP expressed on the tumor cells. Depletion of MT1-MMP, the known activator of MMP2, in tumor cells largely blocked matrix remodeling, even in the presence of stromal cell medium. In summary, these findings implicate an important interplay between MT1-MMP from tumor cells and MMP2 from fibroblasts as a key component for ECM remodeling and invasion.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Células Estromais / Metaloproteinases da Matriz / Matriz Extracelular Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Células Estromais / Metaloproteinases da Matriz / Matriz Extracelular Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos